Verici Dx commercializes RNA signature-based tests that utilize artificial intelligence-assisted transcriptomic analysis to provide clinicians with actionable insights on kidney transplant patients' immune responses and organ health. This technology addresses the risk of transplant injury, rejection, and graft failure by delivering personalized data to improve patient outcomes throughout the transplant journey.
Funding
Funding not disclosed
Founders
Product
Problem
Kidney transplant patients face the risk of transplant injury, rejection, and graft failure due to the complexity of immune responses and the need for personalized monitoring. Clinicians require early, actionable data to understand a patient's response to organ transplant and proactively manage their care.
Solution
Verici Dx offers a suite of RNA signature-based tests that leverage artificial intelligence to provide clinicians with insights into kidney transplant patients' immune responses and overall organ health. These tests analyze transcriptomic data to identify signals related to the risk of injury, rejection, and graft failure, from pre-transplant to late-stage monitoring. By deciphering the body's clinical messages, Verici Dx delivers data-driven insights that enable personalized medical management and improved patient outcomes throughout the transplant journey. The company's technology aims to accelerate innovation through research using fully characterized data and collaboration with medical device, biopharmaceutical, and data science partners.
Target Audience
The primary audience includes clinicians and medical professionals involved in kidney transplantation, specifically those seeking advanced diagnostic tools for personalized patient management and improved transplant outcomes.
Features
- RNA signature-based tests for assessing kidney transplant patient immune response
- AI-assisted transcriptomic analysis to identify critical biological pathway signals
- Tests provide insights into the risk of transplant injury, rejection, and graft failure
- Comprehensive kidney transplant platform for personalized patient and organ response risk assessment
- Designed to assist clinicians in medical management for improved patient outcomes